Suzhou Fushilai Pharmaceutical Co., Ltd. (SHE:301258)
China · Delayed Price · Currency is CNY 34.69
-0.19 (-0.54%)
At close: Feb 12, 2026
SHE:301258 Market Cap
SHE:301258 has a market cap or net worth of 3.09 billion as of February 13, 2026. Its market cap has increased by 48.09% in one year.
Market Cap
3.09B
Enterprise Value
1.76B
Revenue
439.57M
Ranking
n/a
PE Ratio
41.04
Stock Price
34.69
Market Cap Chart
Since March 29, 2022, SHE:301258's market cap has decreased from 6.10B to 3.09B, a decrease of -49.26%. That is a compound annual growth rate of -16.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 3.09B | 6.15% |
| Dec 31, 2025 | 2.91B | 35.37% |
| Dec 31, 2024 | 2.15B | -27.24% |
| Dec 29, 2023 | 2.96B | -17.76% |
| Dec 30, 2022 | 3.60B | -41.00% |
| Mar 29, 2022 | 6.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Model Organisms Center | 3.51B |
| Shanghai Hile Bio-Technology | 3.44B |
| Guangdong VTR Bio-Tech | 3.33B |
| Cabio Biotech (Wuhan) | 3.29B |
| Novoprotein Scientific | 3.04B |
| Landfar Bio-medicine | 2.92B |
| Shanghai Serum Bio-Technology | 2.87B |
| Shanghai Universal Biotech | 2.87B |